Balancing Risk, Cost and Speed During Clinical Development While Still Maintaining Quality

from Cell Culture Dish Podcast · host The Cell Culture Dish

In this podcast, we talked with Thierry Cournez Vice President, BioReliance® End-to-End Solutions, MilliporeSigma. We discussed effective ways for emerging biotechs to collect material quickly and cost-effectively for pre-clinical and clinical studies. We also discussed managing the need to move quickly with cost and quality.

Episode metadata supplied by the publisher feed · Published Jul 27, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Balancing Risk, Cost and Speed During Clinical Development While Still Maintaining Quality

0:00 11:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cell Culture Dish Podcast?

This episode is 11 minutes long.

When was this Cell Culture Dish Podcast episode published?

This episode was published on July 27, 2020.

Can I download this Cell Culture Dish Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!